SENORES — Senores Pharmaceuticals Balance Sheet
0.000.00%
- IN₹23.66bn
- IN₹26.24bn
- IN₹2.15bn
Annual balance sheet for Senores Pharmaceuticals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|
Period Length: | — | — | — |
Source: | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS |
Status: | Final | Final | Final |
Cash | |||
Cash and Equivalents | |||
Short Term Investments | |||
Cash and Short Term Investments | 32.1 | 1 | 131 |
Net Total Accounts Receivable | |||
Net Total Receivables | 207 | 402 | 1,927 |
Total Inventory | |||
Prepaid Expenses | |||
Total Other Current Assets | |||
Total Current Assets | 271 | 513 | 2,509 |
Gross Property, Plant And Equipment | |||
Accumulated Depreciation | |||
Net Property, Plant And Equipment | 61.2 | 153 | 1,791 |
Net Goodwill | |||
Net Intangible Assets | |||
Long Term Investments | |||
Long Term Notes Receivable | |||
Other Long Term Assets | |||
Total Assets | 592 | 1,311 | 6,219 |
Accounts Payable | |||
Notes Payable / Short Term Debt | |||
Current Portion of Long Term Debt / Capital Leases | |||
Total Other Current Liabilities | |||
Total Current Liabilities | 98.8 | 519 | 2,475 |
Long Term Debt | |||
Capital Lease Obligations | |||
Total Long Term Debt | |||
Total Debt | |||
Deferred Income Tax | |||
Minority Interest | |||
Total Other Liabilities | |||
Total Liabilities | 226 | 856 | 4,176 |
Common Stock | |||
Additional Paid In Capital | |||
Retained Earnings (Accumulated Deficit) | |||
Other Equity | |||
Total Equity | 366 | 455 | 2,043 |
Total Liabilities & Shareholders' Equity | 592 | 1,311 | 6,219 |
Total Common Shares Outstanding |